Curis CRIS
NASDAQ CRIS
$1.20 -0.07 (-5.51%)
At close: Sep 9, 2026 · 4:00 PM EDT

Curis (CRIS) Receivables - Net (2010 - 2025)

Curis' (CRIS) quarterly Receivables - Net came in at $3.2 million in Q3 2025, up 8.9% on a YoY basis from $3.0 million in Q3 2024, and up 17.84% quarter-over-quarter from $2.8 million in Q2 2025.

Analysis

Curis (CRIS) Receivables - Net (2010 - 2025) Analysis & Trends

Curis (CRIS) has reported Receivables - Net for 16 consecutive years, with $3.2 million the latest figure, recorded in Q3 2025.

  • For the quarter ending Q3 2025, Receivables - Net rose 8.9% year-over-year to $3.2 million; the trailing twelve-month figure through Sep 2025 stood at $3.2 million (up 8.9% YoY), and the FY2024 full-year result was $3.3 million, up 19.86% from the prior year.
  • Receivables - Net advanced to $3.2 million in Q3 2025 per CRIS's latest filing, from $2.8 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $3.3 million in Q4 2024 and bottomed at $2.1 million in Q1 2022.
  • Historically, Receivables - Net has averaged $2.7 million across 5 years, with a median of $2.8 million in 2025.
  • The sharpest annual moves came in 2021 and 2024: Receivables - Net dropped 12.92% in 2021, then grew 19.86% in 2024.
  • Over 5 years, Receivables - Net stood at $3.2 million in 2021, then fell by 7.72% to $3.0 million in 2022, then fell by 6.08% to $2.8 million in 2023, then increased by 19.86% to $3.3 million in 2024, then fell by 3.17% to $3.2 million in 2025.
  • According to Business Quant data, Receivables - Net over the past three periods registered $3.2 million, $2.8 million, and $2.3 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 Curis 2.63 Mn -2.99 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 3.24 Mn
Jun 30, 2025 2.75 Mn
Mar 31, 2025 2.32 Mn
Dec 31, 2024 3.35 Mn
Sep 30, 2024 2.98 Mn
Jun 30, 2024 2.55 Mn
Mar 31, 2024 2.15 Mn
Dec 31, 2023 2.79 Mn
Sep 30, 2023 2.85 Mn
Jun 30, 2023 2.39 Mn
Mar 31, 2023 2.31 Mn
Dec 31, 2022 2.98 Mn
Sep 30, 2022 2.89 Mn
Jun 30, 2022 2.40 Mn
Mar 31, 2022 2.06 Mn
Dec 31, 2021 3.22 Mn
Sep 30, 2021 2.96 Mn
Jun 30, 2021 2.38 Mn
Mar 31, 2021 2.18 Mn
Dec 31, 2020 3.04 Mn